REVALOR-H- trenbolone acetate and estradiol implant

Revalor-H by

Drug Labeling and Warnings

Revalor-H by is a Animal medication manufactured, distributed, or labeled by Merck Sharp & Dohme Corp.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPL UNCLASSIFIED SECTION

For Heifers
Fed In Confinement
For Slaughter

DESCRIPTION

DESCRIPTION

Revalor®-H (trenbolone acetate and estradiol) is an implant containing 140 mg of trenbolone acetate and 14 mg estradiol. Each implant consists of 7 small yellow pellets. Ten implants are provided in a cartridge.

Manufactured by a non-sterilizing process.

INDICATIONS & USAGE

INDICATIONS FOR USE

Increases rate of weight gain and improves feed efficiency in a slow-release delivery system.

Do not use in veal calves. Effectiveness and animal safety in veal calves have not been established.

SPL UNCLASSIFIED SECTION

NOTE

Studies have demonstrated that the administration of Revalor®-H can result in decreased marbling scores when compared to non-implanted heifers.

DOSAGE & ADMINISTRATION

DOSAGE

One implant containing 140 mg trenbolone acetate and 14 mg estradiol is administered to each animal. The 7 small pellets which make up the dosage of Revalor®-H are contained in one division of the multiple dose cartridge. Ten doses are in each cartridge.

The cartridge is designed to be used with a special implant gun.

ROUTE, METHOD AND FREQUENCY OF ADMINISTRATION

ROUTE OF ADMINISTRATION

The implant is placed under the skin on the posterior aspect of the ear by means of a special implanter available from Intervet Inc.

With the animal suitably restrained, the skin on the outer surface of the ear should be cleaned. The implant is then administered by the method shown in the diagram below.

SPL UNCLASSIFIED SECTION

SITE OF IMPLANTATION

After appropriately restraining the animal to allow access to the ear, cleanse the skin at the implant needle puncture site. It is subcutaneous between the skin and cartilage on the back side of the ear and below the midline of the ear. The implant must not be placed closer to the head than the edge of the cartilage ring farthest from the head. The location of insertion of the needle is a point toward the tip of the ear and at least a needle length away from the intended deposition site. Care should be taken to avoid injuring the major blood vessels or cartilage of the ear.

SPL UNCLASSIFIED SECTION

METHOD OF USE

1. Do not remove the cap of the cartridge containing the implants.
2. Place the cartridge (D) with the capped end to the front into slot at the top of the implanter magazine marked (A) on the diagram.
3. Gently push the cartridge into the slot until it clicks into place.
4. The implanter is then ready for use.
5. Take the ear of the animal firmly with the free hand in the manner shown in Fig. 1. Then insert the needle into the subcutaneous tissue at the point indicated in Fig. 2.
6. After inserting the needle to its full extent, squeeze the trigger (E) gradually. Allow the pellets of the implant to be deposited in a single row.
7. Withdraw the implanter. This will advance the cartridge one groove in the magazine and the next implant is now ready for use.
8. When all the implants have been administered, the cartridge will discharge out the bottom of the magazine and may be replaced by a new one.
9. To change the needle, loosen the needle locking nut labeled (F) in Fig. 3 and replace the needle. Tighten the nut finger tight and the implanter is ready for use.

WARNINGS

WARNING

Not to be used in animals intended for subsequent breeding, or in dairy animals. For Animal Treatment Only. Not for Use in Humans. Implant pellets in the ear only. Any other location is in violation of Federal Law. Do not attempt salvage of implanted site for human or animal food.

A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.

STORAGE AND HANDLING

STORAGE CONDITIONS

Store unopened product at or below 25°C (77°F). Avoid excessive heat and humidity. Use product before the expiration date printed on the label and on the cartridge pouch. Opened cartridges may be stored in the foil pouch protected from light in the refrigerator (2-8°C/36-47°F) for up to 6 months.

HOW SUPPLIED

HOW SUPPLIED

Box of 10 × 10 cartridge implants.

SPL UNCLASSIFIED SECTION

Made in Austria by:
Intervet GesmbH

Distributed by:
Intervet Inc (d/b/a Merck Animal Health)
Madison, NJ 07940

Restricted Drug (California) - Use only as Directed

Rev. 03/15

NADA # 140-992, Approved by FDA

Revalor is a registered trademark of Intervet Inc. or an affiliate.

152334 R1

PRINCIPAL DISPLAY PANEL - 10 x 10 Cartridge Implants Carton

Revalor®-H
(trenbolone acetate and estradiol)

For Heifers
Fed In Confinement
For Slaughter

Box of 10 x 10 Cartridge Implants

Manufactured by a non-sterilizing process

Restricted Drug (California) - use only as directed.

MERCK
Animal Health

INGREDIENTS AND APPEARANCE

REVALOR-H 
trenbolone acetate and estradiol implant

Product Information
Product Type	OTC ANIMAL DRUG	Item Code (Source)	NDC: 57926-023
Route of Administration	SUBCUTANEOUS

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
trenbolone acetate (UNII: RUD5Y4SV0S) (trenbolone - UNII:P53R4420TR)	trenbolone acetate	140 mg
estradiol (UNII: 4TI98Z838E) (estradiol - UNII:4TI98Z838E)	estradiol	14 mg

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 57926-023-01	10 in 1 CARTON
1		10 in 1 CARTRIDGE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
NADA	NADA140992	12/13/1994

Labeler - Merck Sharp & Dohme Corp. (001317601)